Nagendran Sukumar

President and Head of R&D at TSHA; Sr. VP & Chief Medical Officer at AveXis, Inc.

Sold, on record
$8.2M
Dollars the filings state
Form 4 sales
19
Latest Jul 10, 2026
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • TSHATaysha Gene Therapies, Inc.President and Head of R&D
  • AveXis, Inc.Sr. VP & Chief Medical Officer

Sales by reason

3
Routine
0
Plan not stated
1
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale AveXis, Inc.Unusual
    Mar 1 2018

    Sold 1,780 shares at $126.19 ($225k)

    Nagendran Sukumar, Sr. VP & Chief Medical Officer

    Sold 100% of holdings ($225k position)0 shares left1x usual sizeFiling

  2. 2 Form 4 sale TSHANo plan
    Aug 21 +2730 days

    Sold 57,054 shares at $2.85 ($163k)

    Nagendran Sukumar, President and Head of R&D

    No 10b5-1 planSold 4.7% of holdings ($3.5M position)1.2M shares leftFirst sale on recordFiling

  3. 3 Form 4 sale TSHARoutine
    Sep 10 +20 days

    Sold 200,000 shares at $3.23 ($646k)

    Nagendran Sukumar, President and Head of R&D

    10b5-1 planSold 16.6% of holdings ($3.9M position)1M shares leftFiling

  4. 4 Form 4 sale TSHAUnusual
    Dec 1 +82 days

    Sold 370,172 shares at $4.58 ($1.7M)

    Nagendran Sukumar, President and Head of R&D

    No 10b5-1 planSold 26.9% of holdings ($6.3M position)1M shares leftFiling

  5. 5 Form 4 sale TSHARoutine
    Jan 12 +42 days

    Sold 200,000 shares at $4.71 ($942k)

    Nagendran Sukumar, President and Head of R&D

    10b5-1 planSold 16.6% of holdings ($5.7M position)1M shares left1x usual sizeFiling

  6. 6 Form 4 sale TSHANo plan
    Jan 26 +14 days

    Sold 116,050 shares at $4.72 ($547k)

    Nagendran Sukumar, President and Head of R&D

    No 10b5-1 planSold 8.1% of holdings ($6.8M position)1.3M shares left0.6x usual sizeFiling

  7. 7 Form 4 sale TSHARoutine
    Apr 10 +74 days

    Sold 200,000 shares at $4.46 ($892k)

    Nagendran Sukumar, President and Head of R&D

    10b5-1 planSold 15% of holdings ($6M position)1.1M shares left1x usual sizeFiling

  8. 8 Form 4 sale TSHARoutine
    Jul 10 +91 days

    Sold 200,000 shares at $6.24 ($1.2M)

    Nagendran Sukumar, President and Head of R&D

    10b5-1 planSold 17.6% of holdings ($7.1M position)936,410 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (19)

Form 144 notices and Form 4 sales by Nagendran Sukumar
Source
Jul 10, 2026TSHAPresident and Head of R&DForm 4 sale200,000$1.2M17.6%RoutineSEC
Apr 10, 2026TSHAPresident and Head of R&DForm 4 sale200,000$892k15.0%RoutineSEC
Jan 26, 2026TSHAPresident and Head of R&DForm 4 sale116,050$547k8.1%No planSEC
Jan 12, 2026TSHAPresident and Head of R&DForm 4 sale200,000$942k16.6%RoutineSEC
Dec 1, 2025TSHAPresident and Head of R&DForm 4 sale370,172$1.7M26.9%UnusualSEC
Sep 10, 2025TSHAPresident and Head of R&DForm 4 sale200,000$646k16.6%RoutineSEC
Aug 21, 2025TSHAPresident and Head of R&DForm 4 sale57,054$163k4.7%No planSEC
Mar 1, 2018AveXis, Inc.Sr. VP & Chief Medical OfficerForm 4 sale1,780$225k100.0%UnusualSEC
Feb 1, 2018AveXis, Inc.Sr. VP & Chief Medical OfficerForm 4 sale1,780$210k100.0%UnusualSEC
Jan 2, 2018AveXis, Inc.Sr. VP & Chief Medical OfficerForm 4 sale1,780$195k100.0%UnusualSEC
Dec 1, 2017AveXis, Inc.Sr. VP & Chief Medical OfficerForm 4 sale1,780$169k100.0%UnusualSEC
Nov 1, 2017AveXis, Inc.Sr. VP & Chief Medical OfficerForm 4 sale1,780$180k100.0%UnusualSEC
Oct 2, 2017AveXis, Inc.Sr. VP & Chief Medical OfficerForm 4 sale1,780$173k100.0%UnusualSEC
Sep 1, 2017AveXis, Inc.Sr. VP & Chief Medical OfficerForm 4 sale1,780$166k100.0%UnusualSEC
Aug 1, 2017AveXis, Inc.Sr. VP & Chief Medical OfficerForm 4 sale1,780$163k100.0%UnusualSEC
Jul 3, 2017AveXis, Inc.Sr. VP & Chief Medical OfficerForm 4 sale1,780$146k100.0%UnusualSEC
Jun 1, 2017AveXis, Inc.Sr. VP & Chief Medical OfficerForm 4 sale1,780$126k100.0%UnusualSEC
May 1, 2017AveXis, Inc.Sr. VP & Chief Medical OfficerForm 4 sale1,780$145k100.0%UnusualSEC
Apr 3, 2017AveXis, Inc.Sr. VP & Chief Medical OfficerForm 4 sale1,781$136k100.0%UnusualSEC